SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-23-083634
Filing Date
2023-11-06
Accepted
2023-11-06 06:14:31
Documents
14
Period of Report
2023-11-02
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea187742-8k_adialpharma.htm   iXBRL 8-K 38549
2 AMENDMENT NO. 5 TO THE ADIAL PHARMACEUTICALS, INC. 2017 EQUITY INCENTIVE PLAN ea187742ex10-1_adialpharma.htm EX-10.1 8123
  Complete submission text file 0001213900-23-083634.txt   267747

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE adil-20231102.xsd EX-101.SCH 3497
4 XBRL DEFINITION FILE adil-20231102_def.xml EX-101.DEF 26516
5 XBRL LABEL FILE adil-20231102_lab.xml EX-101.LAB 36424
6 XBRL PRESENTATION FILE adil-20231102_pre.xml EX-101.PRE 25140
8 EXTRACTED XBRL INSTANCE DOCUMENT ea187742-8k_adialpharma_htm.xml XML 4991
Mailing Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22901
Business Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22901 434-422-9800
ADIAL PHARMACEUTICALS, INC. (Filer) CIK: 0001513525 (see all company filings)

IRS No.: 800667150 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38323 | Film No.: 231378029
SIC: 2834 Pharmaceutical Preparations